批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/05/01 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/04/11 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/04/11 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/04/11 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/12/20 |
ORIG-1(原始申请) |
Approval |
Not Applicable |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMOXICILLIN; CLAVULANATE POTASSIUM 剂型/给药途径:FOR SUSPENSION;ORAL 规格:600MG/5ML;EQ 42.9MG BASE/5ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050755 |
001 |
NDA |
AUGMENTIN ES-600 |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
Yes |
No |
AB |
2001/06/22
|
US ANTIBIOTICS |
065162 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
Yes |
AB |
2004/03/12
|
TEVA |
065358 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
No |
AB |
2007/08/13
|
SANDOZ INC |
065373 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
No |
AB |
2007/11/09
|
HIKMA PHARMS |
201091 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
No |
AB |
2011/12/20
|
AUROBINDO PHARMA LTD |
065420 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
No |
AB |
2013/12/02
|
CIPLA |
209351 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
No |
AB |
2023/09/13
|
DEVA HOLDING AS |
217805 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
600MG/5ML;EQ 42.9MG BASE/5ML |
Prescription |
No |
No |
AB |
2023/12/08
|
MICRO LABS |